Core Viewpoint - Kyverna Therapeutics, Inc. has announced a public offering of 13,333,333 shares at a price of $7.50 per share, aiming to raise approximately $100 million before expenses [1][2]. Company Overview - Kyverna Therapeutics is a clinical-stage biopharmaceutical company focused on developing cell therapies for autoimmune diseases, with its lead candidate being miv-cel, an autologous CD19-targeting CAR T-cell therapy [5][6]. Offering Details - The public offering is expected to close on or about December 18, 2025, pending customary closing conditions [1]. - The underwriters have a 30-day option to purchase up to 1,999,999 additional shares at the public offering price [1]. Management and Underwriters - J.P. Morgan, Leerink Partners, Morgan Stanley, and Wells Fargo Securities are acting as joint book-running managers for the offering [2].

BREAKING: Futures Rise; Oil Prices Bounce On Trump Move Today's Spotlight IBD's 12 Days of Holiday Deals Celebrate the holidays with big discounts on IBD's premium products every day from Dec. 13-24. Get Market Insights on IBD Live Join IBD Live to watch and discuss the market action in real time with a team of top market analysts. Is the Santa Claus Rally Real? Something big may be coming to town—check out IBD's guide to the Santa Claus Rally. More News INVESTING RESOURCES Take a Trial Today Partner Center ...

Joining us right now is Rich Greenfield, Lightshed Partners. Uh you've probably now had some opportunity to go through uh the document that Warner Brothers put out. You've seen what Netflix had to say about it.Which in your mind is the better deal, Rich. Putting aside whether we get to a bidding war, which I'm sure we will, but or or we may at least right now. >> I mean, I don't even think it's close, Andrew.I mean, think about the things that you learned in this document. I mean, just right off the bat, th ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven safety and robotics solutions company, today announced that it has established a non-binding supplier framework to support the deployment of its solutions for a government agency in Japan. The framework outlines a collaborative path to introduce AMC’s quadruped robotics platform and expand its capabilities for the Japanese market. This includes joint work on AI-powered security ...

Core Insights - GreensKeeper Asset Management reported a +4.0% gain for its Value Fund in Q3 2025, with a year-to-date return of +0.2% net of fees and expenses, despite a -3.7% negative impact from the US dollar [1] - The market rally in 2025 was primarily driven by AI, cryptocurrency, and speculative investments [1] Company Analysis: Fiserv, Inc. (NASDAQ:FISV) - Fiserv, Inc. experienced a one-month return of 13.27%, but its shares have lost 66.45% of their value over the past 52 weeks, closing at $67.70 with a market capitalization of $36.801 billion on December 16, 2025 [2] - Fiserv was the largest detractor for GreensKeeper in Q3 2025, declining -25.2% due to negative market reactions to decelerating volume growth in its Clover platform [3] - Despite the recent decline, the company maintains a competitive position and is expected to grow at attractive rates; shares are viewed as significantly undervalued at 13x earnings, prompting the firm to increase its position [3] - Fiserv is actively buying back shares in the open market, indicating management's confidence in the company's future [3] Hedge Fund Interest - Fiserv, Inc. was held by 83 hedge fund portfolios at the end of Q3 2025, a decrease from 94 in the previous quarter, suggesting a decline in popularity among hedge funds [4] - While Fiserv is recognized for its potential, certain AI stocks are considered to offer greater upside potential with less downside risk [4]

I write about stocks I’m personally interested in adding to my portfolio. I’m not a professional advisor, but I study business and economics and analyze markets full-time. My writing is meant for both complete beginners — I avoid unnecessary complexity — and advanced readers, as I always aim to offer a distinct and well-reasoned perspective.I also run a YouTube Channel called "The Market Monkeys" and break some of the stocks there as well.Analyst’s Disclosure:I/we have no stock, option or similar derivative ...

Key Takeaways COLB's Q3 revenue rose 17%, boosted by NII, fee income, and early Pacific Premier integration benefits.Pacific Premier adds fee engines like trust services and escrow, lifting durable non-interest income.Operating expenses and uneven credit costs may weigh as COLB completes integration through early 2026.Columbia Banking (COLB) intends to reaccelerate revenues, while reshaping its balance sheet after closing the Pacific Premier acquisition. Margin actions and fee income platforms are building ...

Core Insights - The article discusses stocks of interest for potential portfolio addition, emphasizing a blend of simplicity for beginners and depth for advanced readers [1] Group 1 - The author analyzes business and economic trends, aiming to provide a well-reasoned perspective on market opportunities [1] - A YouTube channel named "The Market Monkeys" is mentioned, where the author breaks down stock analyses [1] Group 2 - There is a disclosure indicating no current stock or derivative positions in the companies mentioned, but a potential long position in AVGO may be initiated within 72 hours [2] - The article expresses personal opinions and is not compensated beyond the platform it is published on [2]

FREUDENSTADT, Germany, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SCHMID Group N.V. (NASDAQ: SHMD), a global leader in providing solutions to the high-tech electronics, photovoltaics, glass, and energy systems industries, reports its unaudited financial results for the first half of 2025, covering the period ended June 30, 2025 and updates its full-year 2025 guidance. Key Highlights Revenues: €16.9 million for the six months ended June 30, 2025 compared to €29.7 million for the same period last year due to lower ord ...

Core Insights - Amazon's stock performance has been relatively stagnant this year, showing little change in value [1] - A potential $10 billion deal with OpenAI could either invigorate investor interest or exacerbate concerns regarding an AI market bubble [1] Company Summary - Amazon's stock is described as "near flat," indicating a lack of significant movement in its share price throughout the year [1] - The reported deal with OpenAI, valued at $10 billion, is a substantial investment that may attract investor attention [1] Industry Summary - The potential deal with OpenAI raises questions about the sustainability of the AI sector, with fears of an impending bubble being a concern for investors [1]